Viscosupplementation Market Segment Analysis
The global viscosupplementation market includes segments like hyaluronic acid type, procedure type, application, and end-user to facilitate an easy understanding of the market. This method provides a closer look at the market that can ensure better growth in the coming years.
By hyaluronic acid type, the global market report for the viscosupplementation market includes stabilized hyaluronic acid and standard hyaluronic acid. The stabilized hyaluronic acid segment has the largest market share as its impurity level is close to zero.
Viscosupplementation injections, also known as hyaluronic acid injections, have gained popularity as a non-surgical alternative for managing osteoarthritis-related pain. The therapy works by restoring the viscosity and elasticity of synovial fluid, the natural lubricant in joints, which tends to diminish in osteoarthritis patients. This enhances joint lubrication, reduces friction, and alleviates pain, offering relief to those with mild to moderate osteoarthritis symptoms.
By procedure type, the market report on the viscosupplementation market comprises three-injection procedure, single-injection procedure, and five-injection procedure. The three-injection procedure segment has a better opportunity to maintain its robust growth as it is lower in price when compared with the single-injection procedures and takes less time than the five-injection procedure. Its CAGR could cross a valuation of USD 2602.58 million during the forecast period.
By application, the market report covering the viscosupplementation market includes knee arthritis and hip osteoarthritis. The knee arthritis segment has a better market share than hip osteoarthritis.
By end user, the market report can be segmented into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment has a larger share owing to people preferring this setup for their treatment.
Viscosupplementation Market Regional Analysis
The Americas stood at the top in 2017 and has the opportunity to score the highest CAGR in the coming years. The demand for knee replacement surgeries with increasing thrust from the minimally-invasive procedures can trigger the growth of viscosupplementation procedures.
The Asia-Pacific region has the second-largest market share and can score well-past USD 447.24 million valuations by 2023 with a CAGR of 10.48% during the forecast period. The region would witness contributions made by countries like China, India, and others. These are countries with high expenditure capacity and huge patient pool. In Europe, the growth would be the most in the UK, where increased awareness regarding the procedure would trigger better growth.
Hospital-Acquired Infections Market